BRPI0806972A2 - Composto cíclico contendo ponte azo - Google Patents

Composto cíclico contendo ponte azo

Info

Publication number: BRPI0806972A2
Authority: BR; Brazil
Prior art keywords: compound containing; cyclic compound; containing azo; azo bridge; bridge
Prior art date: 2007-02-09

Application number

BRPI0806972-7A2A

Other languages

English (en)

Inventor

Shinya Nagashima

Toru Kontani

Hiroshi Nagata

Yuji Matsushima

Hisao Hamaguchi

Tadatsura Koshika

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-09

Filing date

2008-02-08

Publication date

2014-04-08

2008-02-08 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2014-04-08 Publication of BRPI0806972A2 publication Critical patent/BRPI0806972A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI0806972-7A2A 2007-02-09 2008-02-08 Composto cíclico contendo ponte azo BRPI0806972A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007030963		2007-02-09
PCT/JP2008/052189 WO2008096870A1 (ja)	2007-02-09	2008-02-08	アザ架橋環化合物

Publications (1)

Publication Number	Publication Date
BRPI0806972A2 true BRPI0806972A2 (pt)	2014-04-08

Family

ID=39681769

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0806972-7A2A BRPI0806972A2 (pt)	2007-02-09	2008-02-08	Composto cíclico contendo ponte azo

Country Status (12)

Country	Link
US (1)	US8367696B2 (pt)
EP (1)	EP2119716A4 (pt)
JP (1)	JP5293192B2 (pt)
KR (1)	KR20090107567A (pt)
CN (1)	CN101605784B (pt)
AU (1)	AU2008212171A1 (pt)
BR (1)	BRPI0806972A2 (pt)
CA (1)	CA2678193A1 (pt)
IL (1)	IL200152A0 (pt)
MX (1)	MX2009008509A (pt)
RU (1)	RU2441868C2 (pt)
WO (1)	WO2008096870A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8314119B2 (en)	2006-11-06	2012-11-20	Abbvie Inc.	Azaadamantane derivatives and methods of use
JP5566698B2 (ja) *	2007-03-23	2014-08-06	アッヴィ・インコーポレイテッド	アザアダマンタンエステルおよびカーバメート誘導体ならびにそれらの使用方法
RU2016105706A (ru)	2010-09-23	2018-11-22	Эббви Бахамаз Лтд.	Моногидрат производного азаадамантана
MA37975B2 (fr)	2012-09-11	2021-03-31	Genzyme Corp	Inhibiteurs de synthase de glucosylcéramide
JPWO2014051055A1 (ja) *	2012-09-28	2016-08-22	東レ株式会社	キヌクリジンウレア誘導体及びその医薬用途
US9751875B2 (en) *	2013-07-13	2017-09-05	Beijing Fswelcome Technology Development Co., Ltd.	Quinine compounds, and optical isomers, preparation method and medical use thereof
KR101538846B1 (ko) *	2013-07-30	2015-07-22	동아에스티 주식회사	신규한 바이페닐 유도체 및 그의 제조방법
CN107849035B (zh) *	2015-12-29	2021-12-10	四川海思科制药有限公司	一种苯基杂环衍生物及其在医药上的用途
CA3034535C (en)	2016-08-26	2021-07-06	Dong-A St Co., Ltd.	Novel salt of (r)-(1-methylpyrrolidine-3-yl)methyl(3'-chloro-4'-fluoro-[1,1'-biphenyl]-2-yl)carbamate and a crystal form thereof
KR102239776B1 (ko) *	2016-08-26	2021-04-13	동아에스티 주식회사	(r)-(1-메틸피롤리딘-3-일)메틸(3'-클로로-4'-플루오로-[1,1'-비페닐]-2-일)카바메이트의 신규염 및 이의 결정형
WO2019096226A1 (en)	2017-11-16	2019-05-23	Chengdu Easton Biopharmaceuticals Co., Ltd.	Pasylated vegfr/pdgfr fusion proteins and their use in therapy
US20200308168A1 (en)	2017-12-04	2020-10-01	Friedrich-Alexander-Universität Erlangen-Nürnberg	Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2
BR112022014553A2 (pt)	2020-02-03	2022-09-20	Genzyme Corp	Métodos para tratamento de sintomas neurológicos associados a doenças do armazenamento lisossômic
IL300090A (en)	2020-07-24	2023-03-01	Genzyme Corp	Pharmaceutical preparations containing VENGLUSTAT

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK202388A (da)	1987-04-15	1988-10-16	Beecham Group Plc	Azabicycliske forbindelser og fremgangsmaade til fremstilling deraf
WO1995006635A1 (fr)	1993-09-02	1995-03-09	Yamanouchi Pharmaceutical Co., Ltd.	Derive de carbamate et medicament le contenant
AU685225B2 (en)	1994-02-10	1998-01-15	Yamanouchi Pharmaceutical Co., Ltd.	Novel carbamate derivative and medicinal composition containing the same
CN1140447A (zh) *	1994-02-10	1997-01-15	山之内制药株式会社	新的氨基甲酸酯衍生物及其药物组合物
NZ281718A (en)	1994-03-11	1997-08-22	Yamanouchi Pharma Co Ltd	Heterocyclically-substituted (condensed) thiazoles
JPH08198751A (ja) *	1995-01-19	1996-08-06	Yamanouchi Pharmaceut Co Ltd	カルバメート誘導体
SE9600683D0 (sv)	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
UY25225A1 (es)	1997-10-29	2000-12-29	Smithkline Beecham Plc	Derivados de pleuromutilina utiles como agentes antimicrobianos
UA73543C2 (uk) *	1999-12-07	2005-08-15	Тераванс, Інк.	Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
BR0112297A (pt) *	2000-06-27	2003-05-06	S A L V A T Lab Sa	Compostos carbamatos derivados de arilalquilaminas
DE60113719T2 (de)	2000-12-22	2006-09-28	Almirall Prodesfarma Ag	Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
SK287414B6 (sk) *	2000-12-28	2010-09-07	Laboratorios Almirall, S.A.	Chinuklidínové deriváty a kompozície s ich obsahom
JP2003267977A (ja) *	2002-03-14	2003-09-25	Yamanouchi Pharmaceut Co Ltd	キヌクリジン誘導体
ES2203327B1 (es)	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
PE20040892A1 (es)	2002-08-06	2004-11-19	Glaxo Group Ltd	Antagonistas del receptor muscarinico m3 de acetilcolina
DE10255040A1 (de)	2002-11-26	2004-06-03	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Carbaminsäureester mit anticholinerger Wirksamkeit
TW200538095A (en)	2004-03-11	2005-12-01	Theravance Inc	Biphenyl compounds useful as muscarinic receptor antagonists
EP1765339A4 (en)	2004-06-30	2009-09-02	Glaxo Group Ltd	ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR
US20090012116A1 (en)	2005-07-11	2009-01-08	Naresh Kumar	Muscarinic Receptor Antagonists
EP2076261A2 (en)	2006-10-03	2009-07-08	Ranbaxy Laboratories, Ltd.	Muscarinic receptor antagonists

2008
- 2008-02-08 BR BRPI0806972-7A2A patent/BRPI0806972A2/pt not_active IP Right Cessation
- 2008-02-08 MX MX2009008509A patent/MX2009008509A/es not_active Application Discontinuation
- 2008-02-08 RU RU2009133781/04A patent/RU2441868C2/ru not_active IP Right Cessation
- 2008-02-08 EP EP08711068A patent/EP2119716A4/en not_active Withdrawn
- 2008-02-08 CA CA002678193A patent/CA2678193A1/en not_active Abandoned
- 2008-02-08 US US12/524,758 patent/US8367696B2/en not_active Expired - Fee Related
- 2008-02-08 CN CN2008800044089A patent/CN101605784B/zh not_active Expired - Fee Related
- 2008-02-08 JP JP2008557177A patent/JP5293192B2/ja not_active Expired - Fee Related
- 2008-02-08 AU AU2008212171A patent/AU2008212171A1/en not_active Abandoned
- 2008-02-08 WO PCT/JP2008/052189 patent/WO2008096870A1/ja active Application Filing
- 2008-02-08 KR KR1020097018755A patent/KR20090107567A/ko not_active Ceased
2009
- 2009-07-30 IL IL200152A patent/IL200152A0/en unknown

Also Published As

Publication number	Publication date
CA2678193A1 (en)	2008-08-14
JP5293192B2 (ja)	2013-09-18
RU2441868C2 (ru)	2012-02-10
WO2008096870A1 (ja)	2008-08-14
MX2009008509A (es)	2009-08-20
US20100105658A1 (en)	2010-04-29
AU2008212171A1 (en)	2008-08-14
IL200152A0 (en)	2010-04-15
US8367696B2 (en)	2013-02-05
CN101605784B (zh)	2013-04-10
JPWO2008096870A1 (ja)	2010-05-27
EP2119716A4 (en)	2011-06-01
CN101605784A (zh)	2009-12-16
RU2009133781A (ru)	2011-03-20
KR20090107567A (ko)	2009-10-13
EP2119716A1 (en)	2009-11-18

Publication	Publication Date	Title
BRPI0806972A2 (pt)	2014-04-08	Composto cíclico contendo ponte azo
BRPI0918602A2 (pt)	2015-12-15	composto (i)
EP1985620A4 (en)	2012-08-15	COMPOUND 10a-AZALIDE
EP2101179A4 (en)	2015-04-22	ANALYSIS DEVICE
BRPI1011400A2 (pt)	2016-03-15	ponte provisoria melhorada
EP2208972A4 (en)	2011-06-01	COMBINATION SCALE
BRPI0923592A2 (pt)	2016-01-26	composto
BRPI0912017A2 (pt)	2015-10-06	circuito de ponte
EP2141493A4 (en)	2015-03-11	ANALYSIS DEVICE
BRPI0909142A2 (pt)	2015-08-04	Composto cíclicos e sal do mesmo
BRPI0913805A2 (pt)	2016-11-01	composto
EP2098507A4 (en)	2011-04-06	CYCLIC AMINE COMPOUND
FI20075179A0 (fi)	2007-03-15	Kielisoitin
FI20075663A0 (fi)	2007-09-21	Suljettu silta
IT1391578B1 (it)	2012-01-11	Composti carbazolici bistabili
BRPI0820430A2 (pt)	2015-05-26	Composto
FI20085306L (fi)	2008-12-01	Siltarakenne
FI20070700L (fi)	2009-03-14	DC/DC-silta
BRPI0813104A2 (pt)	2014-12-23	Composto
TH95767B (th)	2009-05-29	สารประกอบชนิดใหม่ ii
SE0701308L (sv)	2008-12-01	Brokonstruktion
SE0700681L (sv)	2008-09-21	Brokonstruktion
ITBO20080018A1 (it)	2009-07-12	Ponte sollevatore
UA14233S (uk)	2007-05-10	Комплект етикеток
UA14232S (uk)	2007-05-10	Комплект етикеток

Legal Events

Date	Code	Title	Description
2015-03-31	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2015-08-11	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.